STOCK TITAN

Frontline Plc (FRO) Financials

FRO NYSE
FY2025 annual
Revenue $2.0B -8.8% YoY
Net Income $379.1M -23.5% YoY
EPS (Diluted) $1.70 -23.8% YoY
Free Cash Flow $669.9M n/m YoY
Market Cap $12.3B as of Oct 26, 2026
Price / Sales 6.2x on $2.0B revenue, FY2025
Price / Earnings 32.4x on $379.1M net income, FY2025
Price / Book 4.9x on $2.5B equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Mar 27, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FRO SEC filings page.

Frontline Plc (FRO) reported $2.0B in revenue for fiscal year 2025, down 8.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI FRO FY2025

Frontline converted earnings into cash in FY2025 mainly by sharply reducing investment, while lower revenue and margins weakened operating performance.

FY2025 free cash flow reached $670M as capital expenditures fell to $13M, even though operating cash flow declined 7.3%. The surplus therefore reflects a much lighter investment burden, not improved operating cash generation.

Revenue fell 8.8% in FY2025, and operating margin narrowed 5.8 pp, so the business produced less operating profit from a smaller top line rather than merely experiencing a financing effect. Net income fell 23.5% even as interest expense fell 21.0%, indicating the earnings decline was mainly operating, not driven by higher borrowing cost.

Liabilities fell 16.4% while equity rose 7.3%, making the capital structure less creditor-funded than in FY2024. Debt-to-equity was 1.1x and the current ratio was 1.4x in FY2025, showing lower leverage without eliminating the need to manage near-term obligations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 59 / 100
Financial Health Score 59/100
Scored as: Energy peer group

Scored against energy companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Frontline Plc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
77

Frontline Plc has an operating margin of 30.4%, meaning the company retains $30 of operating profit per $100 of revenue. This strong profitability earns a score of 77/100, reflecting efficient cost management and pricing power. This is down from 36.1% the prior year.

Growth
56

Frontline Plc's revenue declined 8.8% year-over-year, from $2.2B to $2.0B. This contraction results in a growth score of 56/100.

Leverage
43

Frontline Plc has a moderate D/E ratio of 1.09. This balance of debt and equity financing earns a leverage score of 43/100.

Liquidity
56

Frontline Plc's current ratio of 1.43 indicates adequate short-term liquidity, earning a score of 56/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
51

Frontline Plc has a free cash flow margin of 34.0%, earning a moderate score of 51/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
72

Frontline Plc earns a strong 15.1% return on equity (ROE), meaning it generates $15 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 72/100. This is down from 21.2% the prior year.

Altman Z-Score Safe
3.17

Frontline Plc scores 3.17, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $12.3B against total liabilities of $3.2B. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
6/8

Frontline Plc passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.

Earnings Quality Cash-Backed
1.80x

For every $1 of reported earnings, Frontline Plc generates $1.80 in operating cash flow ($682.5M OCF vs $379.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate
2.57x

Frontline Plc earns $2.57 in operating income for every $1 of interest expense ($598.8M vs $233.2M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2.0B
YoY-8.8%
5Y CAGR+10.0%
10Y CAGR+15.7%

Frontline Plc generated $2.0B in revenue in fiscal year 2025. This represents a decrease of 8.8% from the prior year.

Net Income
$379.1M
YoY-23.5%
5Y CAGR-1.7%
10Y CAGR+9.4%

Frontline Plc reported $379.1M in net income in fiscal year 2025. This represents a decrease of 23.5% from the prior year.

EPS (Diluted)
$1.70
YoY-23.8%
5Y CAGR-4.0%

Frontline Plc earned $1.70 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 23.8% from the prior year.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
$669.9M
YoYn/m

Frontline Plc generated $669.9M in free cash flow in fiscal year 2025, representing cash available after capex. The change from the prior year is not meaningful, because that figure was zero or negative.

Cash & Debt
$251.3M
YoY-39.2%
5Y CAGR+7.5%
10Y CAGR-0.5%

Frontline Plc held $251.3M in cash against $2.7B in long-term debt as of fiscal year 2025.

Shares Outstanding
223M
YoY0.0%
5Y CAGR+2.4%

Frontline Plc had 223M shares outstanding in fiscal year 2025. That is unchanged from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Operating Margin
30.4%
YoY-5.8pp
5Y change-11.2pp
10Y change-32.2pp

Frontline Plc's operating margin was 30.4% in fiscal year 2025, reflecting core business profitability. This is down 5.8 percentage points from the prior year.

Net Margin
19.2%
YoY-3.7pp
5Y change-14.6pp
10Y change-14.5pp

Frontline Plc's net profit margin was 19.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 3.7 percentage points from the prior year.

Return on Equity
15.1%
YoY-6.1pp
5Y change-10.5pp
10Y change+4.4pp

Frontline Plc's ROE was 15.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 6.1 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Capital Allocation

Capital Expenditures
$12.5M
YoY-98.6%

Frontline Plc invested $12.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 98.6% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Share Buybacks

Not reported for fiscal year 2025.

FRO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FRO annual income statement
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-FFY1420-FFY1320-FFY1220-FFY1120-F
Revenue$2.0B-8.8%$2.2B+18.4%$1.8B+27.0%$1.4B+90.9%$753.4M-38.3%$1.2B+27.6%$957.3M+29.0%$742.3M+14.8%$646.3M-14.3%$754.3M+64.4%$458.9M+89.8%$241.8M+80.6%$133.9M-76.8%$578.4M-20.1%$723.5M
SG&A ExpensesN/AN/AN/AN/AN/A$44.2M-1.7%$45.0M+20.7%$37.3M-0.8%$37.6M+1.6%$37.0M+249.9%$10.6M+114.1%$4.9M+28.4%$3.9M-88.6%$33.9M-5.5%$35.9M
Operating Income$598.8M-23.4%$781.7M+4.7%$746.7M+67.6%$445.6M+5158.0%$8.5M-98.3%$507.8M+112.0%$239.5M+189.6%$82.7Mn/m-$196.3M-210.6%$177.5M-38.2%$287.2M+137.9%$120.7M+83.6%$65.8M+247.8%$18.9Mn/m-$406.8M
EBITDAN/AN/AN/AN/AN/A$658.2M+76.4%$373.2M+61.3%$231.4M+2291.3%$9.7M-97.0%$318.5M-6.3%$339.8M+122.8%$152.6M+67.8%$90.9M-32.0%$133.8Mn/m-$211.2M
Interest Expense$233.2M-21.0%$295.1M+72.2%$171.3M+278.0%$45.3Mn/m$0-100.0%$72.2M-23.6%$94.5M+1.3%$93.3M+33.6%$69.8M+23.2%$56.7M+221.7%$17.6M+137.4%$7.4M-38.4%$12.0M-87.2%$94.1M-30.8%$136.0M
Income Tax$6.0M-21.5%$7.7M+3642.0%$205K-50.2%$412K-91.1%$4.6Mn/m-$14K-104.6%$307K-2.8%$316K+9.0%$290K-15.9%$345K+130.0%$150Kn/m$0n/m$0-100.0%$379K-28.8%$532K
Net Income$379.1M-23.5%$495.6M-24.5%$656.4M+38.0%$475.5Mn/m-$15.0M-103.6%$412.9M+195.0%$140.0Mn/m-$8.9Mn/m-$264.9M-326.4%$117.0M-24.3%$154.6M+3.4%$149.5M+115.1%$69.5Mn/m-$82.8Mn/m-$529.6M
EPS (Basic)$1.70-23.8%$2.23-24.4%$2.95+32.9%$2.22n/m-$0.08-103.8%$2.11+160.5%$0.81n/m-$0.05n/m-$1.56-308.0%$0.75$1.29$1.19+95.1%$0.61n/m-$1.06n/m-$6.80
EPS (Diluted)$1.70-23.8%$2.23-24.4%$2.95+32.9%$2.22n/m-$0.08-103.8%$2.09+167.9%$0.78n/m-$0.05n/m-$1.56-308.0%$0.75$1.29$1.19+95.1%$0.61n/m-$1.06n/m-$6.80
Diluted Shares (Avg)223M0.0%223M0.0%223M+4.0%214M+7.6%199M+0.6%198M+10.3%179M+5.6%170M0.0%170MN/AN/AN/AN/A78M0.0%78M

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

FRO Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FRO annual balance sheet
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-FFY1420-FFY1320-FFY1220-FFY1120-F
Total Assets$5.8B-7.5%$6.2B+5.7%$5.9B+23.4%$4.8B+16.1%$4.1B+4.8%$3.9B+6.0%$3.7B+20.1%$3.1B-1.8%$3.1B+5.6%$3.0B+2.9%$2.9B+15.3%$2.5B+82.9%$1.4B-19.0%$1.7B-8.3%$1.8B
Current Assets$707.3M-14.4%$826.0M+13.5%$727.9M-17.4%$881.0M+164.8%$332.7M-12.0%$378.3M-15.6%$448.5M+45.5%$308.2M-4.2%$321.6M-16.2%$383.6M-17.9%$467.5M+7.0%$436.9M+67.9%$260.2M-33.6%$392.0M-4.5%$410.4M
Cash & Equivalents$251.3M-39.2%$413.5M+34.1%$308.3M+21.1%$254.5M+125.1%$113.1M-35.3%$174.7M+0.3%$174.2M+162.1%$66.5M-36.2%$104.1M-48.5%$202.4M-23.5%$264.5M+12.2%$235.8M-32.2%$347.7M+162.0%$132.7M-17.3%$160.6M
Short-Term InvestmentsN/AN/AN/AN/AN/A$2.6M-27.5%$3.6M+335.6%$836K-95.7%$19.2Mn/m$0n/m$0n/m$0n/m$0n/m$0n/m$0
Inventory$120.1M-12.4%$137.0M+1.4%$135.2M+26.2%$107.1M+32.6%$80.8M+39.6%$57.9M-13.2%$66.7M-3.1%$68.8M+11.4%$61.7M+63.7%$37.7M+46.3%$25.8M+34.7%$19.1M-57.0%$44.5M-22.6%$57.5M+42.4%$40.4M
Accounts Receivable$134.0M+3.9%$128.9M+3.4%$124.6M-10.6%$139.5M+89.7%$73.5M+79.5%$41.0M-35.2%$63.2M+17.2%$54.0M+8.9%$49.6M+1.0%$49.1M-14.4%$57.4M+330.6%$13.3M+12.6%$11.8M-50.1%$23.7M-48.5%$46.0M
Long-Term InvestmentsN/AN/AN/AN/AN/A$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0
Goodwill$112.5M0.0%$112.5M0.0%$112.5M0.0%$112.5M0.0%$112.5M0.0%$112.5M0.0%$112.5M0.0%$112.5M0.0%$112.5M-50.1%$225.3M0.0%$225.3Mn/m$0N/AN/AN/A
Total Liabilities$3.2B-16.4%$3.9B+7.6%$3.6B+43.7%$2.5B+1.8%$2.5B+6.8%$2.3B+5.4%$2.2B+14.3%$1.9B-1.7%$1.9B+32.7%$1.5B+2.0%$1.4B+36.3%$1.1B-23.9%$1.4B-11.0%$1.6B-4.3%$1.6B
Current Liabilities$494.7M-16.9%$595.7M+45.6%$409.1M+4.4%$391.7M+36.5%$287.0M+2.0%$281.4M-66.8%$848.1M+295.9%$214.2M-3.5%$222.0M+21.5%$182.7M-24.5%$242.0M+2.0%$237.2M+81.4%$130.8M-29.9%$186.6M+11.5%$167.4M
Non-Current Liabilities$2.7B-16.3%$3.3B+2.8%$3.2B+51.0%$2.1B-2.8%$2.2B+7.5%$2.0B+51.2%$1.3B-21.2%$1.7B-1.4%$1.7B+34.3%$1.3B+7.4%$1.2B+46.2%$817.2M-34.9%$1.3B-8.4%$1.4B-6.1%$1.5B
Long-Term Debt$2.7B-16.3%$3.3B+2.8%$3.2B+51.2%$2.1B-0.7%$2.1B+8.0%$2.0B+57.0%$1.3B-22.1%$1.6B+9.8%$1.5B+60.4%$914.6M+22.6%$745.7M+57.5%$473.5M+8.5%$436.4M-5.8%$463.3M-6.2%$494.0M
Total Equity$2.5B+7.3%$2.3B+2.8%$2.3B+0.8%$2.3B+37.6%$1.6B+1.9%$1.6B+6.8%$1.5B+29.7%$1.2B-2.0%$1.2B-20.8%$1.5B+3.7%$1.4B+28.7%$1.1Bn/m-$27.0M-122.5%$119.7M-40.5%$201.0M
Retained Earnings$679.5M+33.9%$507.5M+13.8%$446.0M+4.1%$428.5Mn/m-$13.6M-270.0%$8.0Mn/m-$155.1Mn/m-$295.1Mn/m-$272.5M-899.9%$34.1M-58.0%$81.2M-48.1%$156.4Mn/m-$734.3Mn/m-$545.8Mn/m-$463.0M

FRO Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FRO annual cash flow statement
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-FFY1420-FFY1320-FFY1220-FFY1120-F
Operating Cash Flow$682.5M-7.3%$736.4M-14.0%$856.2M+122.2%$385.3M+351.9%$85.3M-85.9%$604.1M+115.6%$280.2M+506.8%$46.2M-64.6%$130.5M-54.4%$286.0M+37.9%$207.3M+253.6%$58.6M+156.6%$22.9M-66.7%$68.6M+20.6%$56.9M
Depreciation & AmortizationN/AN/AN/AN/AN/A$150.4M+12.5%$133.7M-10.1%$148.7M-27.8%$205.9M+46.0%$141.0M+168.1%$52.6M+65.2%$31.8M+26.7%$25.1M-78.1%$114.8M-41.3%$195.6M
Capital Expenditures$12.5M-98.6%$915.2M-43.9%$1.6B+385.8%$335.8M-29.1%$473.8MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow$669.9Mn/m-$178.8Mn/m-$775.2M-1665.7%$49.5Mn/m-$388.5MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Investing Cash Flow$25.0Mn/m-$483.4Mn/m-$1.2Bn/m-$257.3Mn/m-$374.4Mn/m-$716.0Mn/m-$190.6Mn/m-$199.2Mn/m-$722.5Mn/m-$396.4Mn/m-$459.3Mn/m-$63.5Mn/m-$284.2Mn/m-$3.0M-100.7%$434.7M
Financing Cash Flow-$869.6Mn/m-$147.8M-134.1%$433.1M+3121.8%$13.4M-94.1%$227.5M+83.2%$124.2M+525.4%$19.9M-82.9%$116.1M-76.5%$493.8M+915.8%$48.6M-77.9%$219.5Mn/m-$45.9M-109.6%$476.4Mn/m-$88.5Mn/m-$507.6M
Dividends Paid$207.0M-52.3%$434.1M-32.1%$638.9M+1813.4%$33.4Mn/m$0-100.0%$312.4M+1486.7%$19.7M+5000.5%$386K-99.2%$51.4M-68.8%$164.6M+319.5%$39.2M+6.1%$37.0M+2469.1%$1.4Mn/m$0-100.0%$17.1M
Share BuybacksN/AN/AN/AN/AN/AN/AN/AN/AN/A$0n/m$0-100.0%$50.4MN/AN/AN/A

Not reported in any period shown, so not listed: Stock-Based Compensation.

FRO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FRO annual financial ratios
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-FFY1420-FFY1320-FFY1220-FFY1120-F
Operating Margin30.4%-5.8pp36.1%-4.7pp40.9%+9.9pp31.0%+29.9pp1.1%-40.5pp41.6%+16.6pp25.0%+13.9pp11.1%+41.5pp-30.4%-53.9pp23.5%-39.1pp62.6%+12.7pp49.9%+0.8pp49.1%+45.8pp3.3%+59.5pp-56.2%
Net Margin19.2%-3.7pp22.9%-13.0pp35.9%+2.9pp33.1%+35.1pp-2.0%-35.8pp33.8%+19.2pp14.6%+15.8pp-1.2%+39.8pp-41.0%-56.5pp15.5%-18.2pp33.7%-28.1pp61.8%+9.9pp51.9%+66.2pp-14.3%+58.9pp-73.2%
Return on Equity15.1%-6.1pp21.2%-7.7pp28.8%+7.8pp21.0%+21.9pp-0.9%-26.5pp25.6%+16.3pp9.3%+10.0pp-0.8%+21.6pp-22.3%-30.1pp7.8%-2.9pp10.7%-2.6pp13.3%N/A-69.2%+194.3pp-263.5%
Return on Assets6.6%-1.4pp8.0%-3.2pp11.2%+1.2pp10.0%+10.3pp-0.4%-10.9pp10.5%+6.7pp3.8%+4.1pp-0.3%+8.2pp-8.5%-12.4pp3.9%-1.4pp5.4%-0.6pp6.0%+0.9pp5.1%+10.0pp-4.9%+23.9pp-28.8%
Current Ratio1.430.0x1.39-0.4x1.78-0.5x2.25+1.1x1.16-0.2x1.34+0.8x0.53-0.9x1.440.0x1.45-0.7x2.10+0.2x1.93+0.1x1.84-0.1x1.99-0.1x2.10-0.4x2.45
Debt-to-Equity1.09-0.3x1.400.0x1.40+0.5x0.93-0.4x1.29+0.1x1.22+0.4x0.83-0.6x1.38+0.1x1.24+0.6x0.61+0.1x0.52+0.1x0.42N/A3.87+1.4x2.46
Liabilities-to-Equity1.29-0.4x1.66+0.1x1.58+0.5x1.11-0.4x1.50+0.1x1.430.0x1.45-0.2x1.640.0x1.64+0.7x0.980.0x0.99+0.1x0.94N/A13.01+4.9x8.10
Asset Turnover0.340.0x0.350.0x0.310.0x0.30+0.1x0.18-0.1x0.31+0.1x0.260.0x0.240.0x0.210.0x0.25+0.1x0.16+0.1x0.100.0x0.10-0.2x0.34-0.1x0.39
FCF Margin34.0%+42.3pp-8.3%+34.2pp-42.4%-45.9pp3.4%+55.0pp-51.6%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

Not reported in any period shown, so not listed: Gross Margin.

Frequently Asked Questions

What is Frontline Plc's annual revenue?

Frontline Plc (FRO) reported $2.0B in total revenue for fiscal year 2025. This represents a -8.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Frontline Plc's revenue growing?

Frontline Plc (FRO) revenue declined by 8.8% year-over-year, from $2.2B to $2.0B in fiscal year 2025.

Is Frontline Plc profitable?

Yes, Frontline Plc (FRO) reported a net income of $379.1M in fiscal year 2025, with a net profit margin of 19.2%.

Frontline Plc (FRO) reported diluted earnings per share of $1.70 for fiscal year 2025. This represents a -23.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Frontline Plc (FRO) had $251.3M in cash and equivalents against $2.7B in long-term debt.

Frontline Plc (FRO) had an operating margin of 30.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Frontline Plc (FRO) had a net profit margin of 19.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Frontline Plc (FRO) has a return on equity of 15.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Frontline Plc (FRO) generated $669.9M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Frontline Plc (FRO) generated $682.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Frontline Plc (FRO) had $5.8B in total assets as of fiscal year 2025, including both current and long-term assets.

Frontline Plc (FRO) invested $12.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Frontline Plc (FRO) had 223M shares outstanding as of fiscal year 2025.

Frontline Plc (FRO) had a current ratio of 1.43 as of fiscal year 2025, which is considered adequate.

Frontline Plc (FRO) had a debt-to-equity ratio of 1.09 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Frontline Plc (FRO) had a liabilities-to-equity ratio of 1.29 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Frontline Plc (FRO) had a return on assets of 6.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Frontline Plc (FRO) trades at 32.4x earnings, its market capitalization divided by $379.1M net income, FY2025. The market capitalization is $12.3B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Frontline Plc (FRO) trades at 6.2x sales, its market capitalization divided by $2.0B revenue, FY2025. The market capitalization is $12.3B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Frontline Plc (FRO) has an Altman Z-Score of 3.17, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Frontline Plc (FRO) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Frontline Plc (FRO) has an earnings quality ratio of 1.80x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Frontline Plc (FRO) has an interest coverage ratio of 2.57x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Frontline Plc (FRO) scores 59 out of 100 on our Financial Health Score, indicating moderate standing within its energy companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top